期刊文献+

幽门螺杆菌对克拉霉素耐药机制的研究 被引量:7

Study on the Mechanism of Helicobacter Pylori's Resistance to Clarithromycin
下载PDF
导出
摘要 目的明确幽门螺杆菌(heliobacter pylori,Hp)对克拉霉素的耐药情况进而探讨Hp对克拉霉素耐药机制。方法分离培养获得96株Hp。采用琼脂稀释法进行体外抗生素敏感试验,检测Hp对克拉霉素的最低抑菌浓度(minimalinhibitory concentration,MIC),拟定克拉霉素MIC>2μg/m L为耐药菌株。比较城市和农村的差异。挑选克拉霉素耐药Hp10株,提取细菌DNA,用PCR-限制性片段长度多态性(RFLP)分析探讨克拉霉素耐药机制。结果 Hp对克拉霉素的耐药率为25%,城市和农村耐药率差异无统计学意义(P>0.05)。16株克拉霉素耐药菌株23S r RNA基因功能区V PCR扩增片段,均被BsaⅠ酶切,未被BbsⅠ酶切,提示16株在2143位点有A→G突变。结论 Hp对克拉霉素的耐药率较高,且城市和农村无显著差异。大多数克拉霉素耐药Hp存在23Sr RNA基因功能区V 2143位点A→G突变。 Objective Toclarify the resistance of Helicobacter pylori(Hp) to clarithromycin and to explore the mechanism.Methods 96 strains of Hp were obtained by isolation and culture.The minimal inhibitory concentration(MIC) of Hp to clarithromycin was determined by agar dilution method.Clarithromycin resistant strains were determined by MIC 2μg/m L. The difference between urban and rural was compared.The mechanism of clarithromycin resistance was analyzed by PCR-restriction fragment length polymorphism(RFLP) through selecting 10 Clarithromycin resistant Hp strains and extracting their gene. Results The resistance rate of Hp to clarithromycin was 25%,and there was no significant difference in resistance rate between urban and rural areas(P〉0. 05).In the 16 Clarithromyc resistant strains,the PCR amplification fragment of gene functional domain Vof 23 S r RNA were digested by BsaⅠ,but not BbsⅠ,suggesting that there were A → G mutation on the 2143 site in the 16 strains.Conclusion Hp has a higher resistance to clarithromycin,and there is no significant difference between urban and rural areas.Most clarithromycin-resistant Hps present A → G mutation on gene functional domain V2143 site of 23 S r RNA.
出处 《四川医学》 CAS 2017年第10期1143-1146,共4页 Sichuan Medical Journal
关键词 幽门螺杆菌 克拉霉素 耐药性 突变 helicobacter pylori clarithromycin resistance mutation
  • 相关文献

参考文献3

二级参考文献42

  • 1史碧山,佘菲菲,林赛榕,潘玉凤,江勇.幽门螺杆菌检测法比较及药敏试验[J].中华消化内镜杂志,1997,14(1):26-28. 被引量:60
  • 2Dore MP, Leandro G, Realdi G, et al. Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy. Dig Dis Sci, 2000, 45 (1): 68-76.
  • 3Megraud Francis. Epidemiology and mechanism of antibiotic resis tance in helicobacter pylori. Gastroenterology, 1998, 115 (5): 1278 12-82.
  • 4Glupezynski Y. Antimicrobial resistance in Helicobacter pylori: a global overview. Acta Gastroenterol Belg, 1998, 61 (3): 357 366.
  • 5Van Zwet AA, Vandenbrouke Grauls CM, Thijs JC, et al. Stable amoxicillin resistance in Helicobacter pylori. Lancet, 1998, 352 (14): 15-95.
  • 6Banatvala N, Davies GR, Abdi Y, et al. High prevalence of Helicobacter pylori metronidazole resistance in migrant to east London: relation with previous nitroimidazole exposure and gastroduodenal disease. Gut, 1994, 35 (11 12): 1562 15-66.
  • 7Lam SK, Talley NJ. Helicobacter pylori consensus: report of the 1997 Asia Pacific consensus conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol 1998, 13 (1): 1-12.
  • 8Van Der Wouden EJ, Thijs JC, Van Zwet AA, et al. Nitroimi dazole resistance in Helicobacter pylori. Alimint Pharmacol Ther,2000, 14 (1): 7-14.
  • 9Van der Hulst RW, Rauws EA, Koycu B, et al. Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study. Gastroenterology, 1997, 113: 1082-1086.
  • 10Malfertheiner P, Bayerdorffer E, Diete U, et al. The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer. Aliment Pharmacol Ther, 1999, 13: 703-712.

共引文献205

同被引文献78

引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部